resveratrol has been researched along with Parkinson Disease in 26 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (7.69) | 29.6817 |
| 2010's | 14 (53.85) | 24.3611 |
| 2020's | 10 (38.46) | 2.80 |
| Authors | Studies |
|---|---|
| André-Miral, C; Arbo, BD; Dos Santos, MG; Hort, MA; Muccillo-Baisch, AL; Schimith, LE | 1 |
| Bhurtel, S; Choi, DY; Duwa, R; Jeong, JH; Katila, N; Khanal, S; Lee, S; Maharjan, S; Yook, S | 1 |
| Decheng, B; Lixia, Z; Wei, S | 1 |
| Nguyen, HD | 1 |
| Cao, Z; Fu, X; Wang, X; Xia, Q; Zhang, T; Zhong, L; Zhu, J | 1 |
| Al-Awsi, L; Bazmandegan, G; Golmohammadi, M; Heidari, M; Kujawska, M; Lafta, HA; Mustafa, YF; Parra, RMR; Raheem, G; Soltani, A; Taheri, N; Zamanian, MY | 1 |
| Cao, Z; Deng, Y; Li, W; Shi, Y; Song, Q; Yang, X; Zhang, L | 1 |
| Kuo, YC; Rajesh, R; Wang, IH | 1 |
| Huang, J; Huang, N; Jin, F; Jin, H; Li, Y; Luo, Y; Shi, J; Xu, S; Yu, C | 1 |
| Fan, HX; Li, JJ; Li, XX; Sheng, S; Zhang, F; Zheng, CQ | 1 |
| Aliev, G; Cacabelos, R; Carrera, I; Fernandez-Novoa, L; Sampedro, C; Tarasov, VV | 1 |
| Dong, J; Lu, B; Sigears, A; Wu, A; Wu, Z | 1 |
| Ji, M; Liu, RT; Liu, SY; Wang, YJ; Wu, XL; Yu, XL; Zhang, LF | 1 |
| Chen, M; Huang, N; Jin, F; Jin, H; Luo, Y; Nie, J; Shi, J; Zhang, Y; Zhou, S | 1 |
| Annese, T; Bonifati, V; Capitanio, N; Cocco, T; De Mari, M; Dell'aquila, C; Di Paola, M; Ferranini, E; Ferretta, A; Gaballo, A; Nico, B; Pacelli, C; Piccoli, C; Tanzarella, P | 1 |
| Bayer, H; Danzer, KM; Eschbach, J; Fauler, M; Liss, B; Ludolph, AC; McLean, PJ; Morrison, BE; Müller, K; Otto, M; Rudolph, KL; Scheffold, A; Spada, AR; Thal, DR; von Einem, B; Weishaupt, JH; Weydt, P; Witting, A | 1 |
| Ali, J; Baboota, S; Mustafa, G; Pangeni, R; Sharma, S | 1 |
| Ficarra, S; Galtieri, A; Giardina, B; Russo, A; Tellone, E | 1 |
| Elbatsh, MM; Gaballah, HH; Tahoon, NM; Zakaria, SS | 1 |
| Dong, W; Wang, R | 1 |
| Gong, QH; Jin, F; Lu, YF; Shi, JS; Wu, Q | 1 |
| Gao, HM; Hong, JS; Shi, JS; Wilson, B; Zhang, F; Zhou, H | 1 |
| Huber, K; Superti-Furga, G | 1 |
| Fu, Q; Ma, R; Wang, Y; Xiang, J; Xu, H | 1 |
| Beseler, C; Cavalieri, EL; Rogan, E; Saeed, M; Yang, L; Zahid, M | 1 |
| Ramassamy, C | 1 |
8 review(s) available for resveratrol and Parkinson Disease
| Article | Year |
|---|---|
Neuroprotective Effects of Resveratrol in In vivo and In vitro Experimental Models of Parkinson's Disease: a Systematic Review.
Topics: Humans; Models, Theoretical; Neurodegenerative Diseases; Neuroprotective Agents; Parkinson Disease; Resveratrol | 2022 |
Targeting Nrf2 signaling pathway and oxidative stress by resveratrol for Parkinson's disease: an overview and update on new developments.
Topics: Antioxidants; Humans; Neuroprotective Agents; NF-E2-Related Factor 2; Oxidative Stress; Parkinson Disease; Reactive Oxygen Species; Resveratrol; Signal Transduction | 2023 |
Signaling mechanisms underlying inhibition of neuroinflammation by resveratrol in neurodegenerative diseases.
Topics: Alzheimer Disease; Animals; Antioxidants; Humans; Inflammation; Macrophages; Mice; Microglia; Neurodegenerative Diseases; Neurons; Parkinson Disease; Rats; Resveratrol; Signal Transduction | 2021 |
Dopaminergic Neuroprotection with Atremorine in Parkinson´s Disease.
Topics: Animals; Curcumin; Dopaminergic Neurons; Ginsenosides; Humans; Levodopa; Neuroprotective Agents; Parkinson Disease; Resveratrol; Vicia faba | 2018 |
Resveratrol: A Focus on Several Neurodegenerative Diseases.
Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Humans; Huntington Disease; Mitochondria; Neurodegenerative Diseases; Oxidative Stress; Parkinson Disease; Resveratrol; Stilbenes | 2015 |
[Effects of resveratrol-induced cellular autophagy in control of neurodegenerative diseases].
Topics: Alzheimer Disease; Autophagy; Humans; Huntington Disease; Neurodegenerative Diseases; Parkinson Disease; Resveratrol; Stilbenes | 2016 |
After the grape rush: sirtuins as epigenetic drug targets in neurodegenerative disorders.
Topics: Alzheimer Disease; Enzyme Inhibitors; Epigenesis, Genetic; Humans; Neurodegenerative Diseases; Parkinson Disease; Resveratrol; Sirtuins; Stilbenes; Up-Regulation | 2011 |
Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets.
Topics: Alzheimer Disease; Anti-Inflammatory Agents; Antioxidants; Apoptosis; Blueberry Plants; Clinical Trials as Topic; Cognition; Curcumin; Flavonoids; Ginkgo biloba; Humans; Neurodegenerative Diseases; Parkinson Disease; Phenols; Plant Extracts; Polyphenols; Proteasome Endopeptidase Complex; Resveratrol; Signal Transduction; Stilbenes; Tea; Wine | 2006 |
18 other study(ies) available for resveratrol and Parkinson Disease
| Article | Year |
|---|---|
Enhancement of blood-brain barrier penetration and the neuroprotective effect of resveratrol.
Topics: Blood-Brain Barrier; Endothelial Cells; Humans; Nanoparticles; Neuroblastoma; Neuroprotective Agents; Parkinson Disease; Resveratrol | 2022 |
Protective effect of resveratrol on rat cardiomyocyte H9C2 cells injured by hypoxia/reoxygenation by regulating mitochondrial autophagy PTEN-induced putative kinase protein 1/Parkinson disease protein 2 signaling pathway.
Topics: Animals; Autophagy; Humans; Hypoxia; Mitochondrial Diseases; Myocytes, Cardiac; Parkinson Disease; Protein Kinases; PTEN Phosphohydrolase; Rats; Reactive Oxygen Species; Resveratrol; RNA, Messenger; Signal Transduction; Ubiquitin-Protein Ligases; Ubiquitins | 2022 |
Resveratrol, Endocrine Disrupting Chemicals, Neurodegenerative Diseases and Depression: Genes, Transcription Factors, microRNAs, and Sponges Involved.
Topics: Amyotrophic Lateral Sclerosis; Brain-Derived Neurotrophic Factor; Cyclooxygenase 2; Depression; Endocrine Disruptors; Humans; Interleukin-6; MicroRNAs; Neurodegenerative Diseases; Parkinson Disease; Resveratrol; Transcription Factors | 2023 |
2-Hydroxy-4-benzyloxylimine Resveratrol Derivatives as Potential Multifunctional Agents for the Treatment of Parkinson's Disease.
Topics: Animals; Antioxidants; Chelating Agents; Mice; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neuroprotective Agents; Parkinson Disease; Resveratrol | 2023 |
Pyridoxine-resveratrol hybrids as novel inhibitors of MAO-B with antioxidant and neuroprotective activities for the treatment of Parkinson's disease.
Topics: Animals; Antioxidants; Humans; Molecular Docking Simulation; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Neurons; Neuroprotective Agents; Parkinson Disease; PC12 Cells; Pyridoxine; Rats; Resveratrol | 2020 |
Use of leptin-conjugated phosphatidic acid liposomes with resveratrol and epigallocatechin gallate to protect dopaminergic neurons against apoptosis for Parkinson's disease therapy.
Topics: Apoptosis; Catechin; Dopaminergic Neurons; Humans; Leptin; Liposomes; Parkinson Disease; Phosphatidic Acids; Resveratrol | 2021 |
Resveratrol Alleviates Levodopa-Induced Dyskinesia in Rats.
Topics: Animals; Biomarkers; Disease Models, Animal; Dopamine; Dopaminergic Neurons; Dyskinesias; Levodopa; Male; Oxidopamine; Parkinson Disease; Rats; Resveratrol; Substantia Nigra | 2021 |
Grape skin extract improves muscle function and extends lifespan of a Drosophila model of Parkinson's disease through activation of mitophagy.
Topics: Animals; Autophagy; Disease Models, Animal; Drosophila melanogaster; Drosophila Proteins; Longevity; Male; Mitochondria; Mitophagy; Muscles; Mutation; Parkinson Disease; Plant Extracts; Protein Serine-Threonine Kinases; Resveratrol; Vitis | 2018 |
Resveratrol alleviates motor and cognitive deficits and neuropathology in the A53T α-synuclein mouse model of Parkinson's disease.
Topics: alpha-Synuclein; Animals; Cognition; Disease Models, Animal; Humans; Male; Mice; Mice, Transgenic; Motor Activity; Mutation, Missense; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Resveratrol | 2018 |
Resveratrol delays 6-hydroxydopamine-induced apoptosis by activating the PI3K/Akt signaling pathway.
Topics: Animals; Apoptosis; Disease Models, Animal; Dopaminergic Neurons; Dose-Response Relationship, Drug; Gene Expression Regulation; Male; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Resveratrol; Signal Transduction; Substantia Nigra | 2019 |
Effect of resveratrol on mitochondrial function: implications in parkin-associated familiar Parkinson's disease.
Topics: Adenosine Triphosphate; AMP-Activated Protein Kinases; Cells, Cultured; Female; Fibroblasts; Genetic Predisposition to Disease; Humans; Middle Aged; Mitochondria; NAD; Oxidative Stress; Oxygen Consumption; Parkinson Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; Resveratrol; Sirtuin 1; Stilbenes; Transcription Factors; Ubiquitin-Protein Ligases | 2014 |
Mutual exacerbation of peroxisome proliferator-activated receptor γ coactivator 1α deregulation and α-synuclein oligomerization.
Topics: Aged; Aged, 80 and over; alpha-Synuclein; Animals; Cells, Cultured; Cerebral Cortex; Disease Models, Animal; Embryo, Mammalian; Enzyme Inhibitors; Female; Gene Expression Regulation; Glioma; Humans; Macrolides; Male; Mice; Mice, Transgenic; Middle Aged; Neurons; Parkinson Disease; Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha; PPAR gamma; Resveratrol; RNA Polymerase II; Stilbenes; Substantia Nigra; TATA-Box Binding Protein; Transcription Factors | 2015 |
Vitamin E loaded resveratrol nanoemulsion for brain targeting for the treatment of Parkinson's disease by reducing oxidative stress.
Topics: Animals; Antioxidants; Biological Availability; Brain; Chemistry, Pharmaceutical; Emulsions; Female; Male; Nanoparticles; Oxidative Stress; Parkinson Disease; Particle Size; Polysorbates; Rats; Rats, Wistar; Resveratrol; Solubility; Stilbenes; Swine; Viscosity; Vitamin E | 2014 |
Modulatory effects of resveratrol on endoplasmic reticulum stress-associated apoptosis and oxido-inflammatory markers in a rat model of rotenone-induced Parkinson's disease.
Topics: Animals; Apoptosis; Biomarkers; Caspase 3; Chemically-Induced Disorders; Disease Models, Animal; Endoplasmic Reticulum Stress; Enzyme Activation; Gene Expression Regulation; HSP70 Heat-Shock Proteins; Inflammation; Male; Membrane Proteins; Parkinson Disease; Rats; Rats, Wistar; Real-Time Polymerase Chain Reaction; Resveratrol; Rotenone; Stilbenes; Transcription Factor CHOP | 2016 |
Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats.
Topics: Administration, Oral; Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Cyclooxygenase 2; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Male; Neuroprotective Agents; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Resveratrol; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Stilbenes; Tumor Necrosis Factor-alpha | 2008 |
Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions.
Topics: Animals; Anti-Inflammatory Agents; Dopamine; Embryo, Mammalian; Female; Flavonoids; Lipopolysaccharides; Mesencephalon; Mice; Mice, Inbred C57BL; Microglia; Mitogen-Activated Protein Kinases; NADPH Oxidases; Nerve Degeneration; Neuroglia; Neurons; Neuroprotective Agents; Neurotoxicity Syndromes; Parkinson Disease; Phenols; Polyphenols; Pregnancy; Rats; Rats, Inbred F344; Reactive Oxygen Species; Resveratrol; Stilbenes; Substantia Nigra | 2010 |
[Resveratrol derived from rhizoma et radix polygoni cuspidati and its liposomal form protect nigral cells of Parkinsonian rats].
Topics: Animals; Antioxidants; Behavior; Cell Death; Disease Models, Animal; Drugs, Chinese Herbal; Liposomes; Neurons; Neuroprotective Agents; Oxidative Stress; Parkinson Disease; Rats; Rats, Wistar; Reactive Oxygen Species; Resveratrol; Stilbenes; Substantia Nigra | 2011 |
Formation of dopamine quinone-DNA adducts and their potential role in the etiology of Parkinson's disease.
Topics: Acetylcysteine; Antioxidants; Benzoquinones; DNA Adducts; Dopamine; Humans; Hydrogen-Ion Concentration; Kinetics; Melatonin; Monophenol Monooxygenase; Parkinson Disease; Resveratrol; Stilbenes; Thioctic Acid | 2011 |